Accelerated infliximab dosing in ASUC: the uncertainty continues

Management of acute severe ulcerative colitis (ASUC) remains difficult with questions around the optimal timing and dose of infliximab as a rescue therapy in order to prevent colectomy, an Australian gastroenterologist says. Recent British Society of Gastroenterology guidelines (2019) suggest patients treated with infliximab for ASUC who have not responded sufficiently to a 5mg/kg dose ...

Already a member?

Login to keep reading.

© 2021 the limbic